| Title: | Nuclear Hormone Receptors |
|---|---|
| Course Section Number: | CHE-461-02 |
| Department: | Chemistry |
| Description: | 2nd half semester course. According to a recent study, 13% of all FDA approved drugs target nuclear receptors. These include drugs to treat cancer, diabetes, high cholesterol and thyroid diseases. Nuclear receptors are proteins that modulate gene expression through the recruitment of repressor or activator complexes, ultimately controlling expression of downstream gene products. This course will examine the structure and function of the steroid, thyroid and retinoic acid receptors in the cell and drugs that modulate these systems. |
| Credits: | 0.50 |
| Start Date: | October 20, 2025 |
| End Date: | December 20, 2025 |
| Meeting Information: |
10/21/2025-12/18/2025 Lecture Tuesday, Thursday 08:00AM - 09:15AM, Room to be Announced
|
| Faculty: | Novak, Wally |
| Requisite Courses: | CHE-361 |
Course Status
| Section Name/Title | Status | Dept. | Capacity |
Enrolled/ Available/ Waitlist |
|---|---|---|---|---|
|
CHE-461-02
Nuclear Hormone Receptors |
OPEN | Chemistry | 12 | 0 / 12 / 0 |